Psychosis in Parkinson's disease: how should we treat it?
Shotbolt
Paul
P
Samuel
Michael
M
Anthony
David
D
D000978:Antiparkinson Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D006801:Humans; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000639:trends; D011618:Psychotic Disorders / Q000209:etiology* / Q000628:therapy*
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents